{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:55Z","timestamp":1790713195053,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T00:00:00Z","timestamp":1329955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00270-012-0352-x","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T19:20:07Z","timestamp":1329938407000},"page":"1363-1371","source":"Crossref","is-referenced-by-count":60,"title":["Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Shinya","family":"Sahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takami","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Sonomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,23]]},"reference":[{"key":"352_CR1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164\u20131171","journal-title":"Hepatology"},{"key":"352_CR2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"352_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","volume":"224","author":"C Camma","year":"2002","unstructured":"Camma C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47\u201354","journal-title":"Radiology"},{"key":"352_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","volume":"148","author":"R Yamada","year":"1983","unstructured":"Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397\u2013401","journal-title":"Radiology"},{"key":"352_CR5","first-page":"2449","volume":"74","author":"JM Chang","year":"1994","unstructured":"Chang JM, Tzeng WS, Pan HB et al (1994) Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 74:2449\u20132453","journal-title":"A randomized controlled study. Cancer"},{"issue":"Suppl","key":"352_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/BF00687096","volume":"31","author":"S Kawai","year":"1992","unstructured":"Kawai S, Okamura J, Ogawa M et al (1992) prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: A comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol 31(Suppl):S1\u2013S6","journal-title":"Cancer Chemother Pharmacol"},{"key":"352_CR7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11604-010-0436-y","volume":"28","author":"S Sahara","year":"2001","unstructured":"Sahara S, Kawai N, Sato M et al (2001) Prospective comparison of transcatheter arterial chemoembolization with lipiodol-epirubicin and lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma. Jpn J Radiol 28:362\u2013368","journal-title":"Jpn J Radiol"},{"key":"352_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6\u201325","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"Suppl","key":"352_CR9","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF00686670","volume":"33","author":"K Nishimine","year":"1994","unstructured":"Nishimine K, Uchida H, Matsuo N et al (1994) Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33(Suppl):S60\u2013S68","journal-title":"Cancer Chemother Pharmacol"},{"key":"352_CR10","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.RVI.0000182160.26798.A2","volume":"16","author":"DB Brown","year":"2005","unstructured":"Brown DB, Pilgram TK, Darcy MD et al (2005) Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 16:1661\u20131666","journal-title":"J Vasc Interv Radiol"},{"key":"352_CR11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2214\/AJR.08.1806","volume":"193","author":"AS Gomes","year":"2009","unstructured":"Gomes AS, Rosove MH, Rosen PJ et al (2009) Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients. AJR Am J Roentgenol 193:1665\u20131671","journal-title":"AJR Am J Roentgenol"},{"key":"352_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts LH et al (2009) New response evaluation criteria in solid tumours: Revised RECIST (version 1.1). EJC 45:228\u2013247","journal-title":"EJC"},{"key":"352_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"352_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11604-007-0216-5","volume":"26","author":"N Maeda","year":"2008","unstructured":"Maeda N, Osuga K, Mikami K et al (2008) Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 26:206\u2013212","journal-title":"Radiat Med"},{"key":"352_CR15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00000421-200012000-00006","volume":"23","author":"Y Ono","year":"2000","unstructured":"Ono Y, Yoshimasu T, Ashikaga R et al (2000) Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 23:564\u2013568","journal-title":"Am J Clin Oncol"},{"key":"352_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CAD.0b013e328342231d","volume":"22","author":"H Yodono","year":"2011","unstructured":"Yodono H, Matsuo K, Shinohara A et al (2011) A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial embolization for treatment of hepatocellular carcinoma. Anticancer Drugs 22:277\u2013282","journal-title":"Anticancer Drugs"},{"key":"352_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1872-034X.2010.00770.x","volume":"41","author":"K Yamanaka","year":"2011","unstructured":"Yamanaka K, Hatano E, Narita M et al (2011) Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 41:303\u2013309","journal-title":"Hepatol Res"},{"key":"352_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1051-0443(07)61510-3","volume":"12","author":"K Kamada","year":"2001","unstructured":"Kamada K, Nakanishi T, Kitamoto M et al (2001) Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin Lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 12:847\u2013854","journal-title":"J Vasc Interv Radiol"},{"issue":"Suppl","key":"352_CR19","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/BF00687105","volume":"31","author":"T Ichida","year":"1992","unstructured":"Ichida T, Kato M, Hayakawa A et al (1992) Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study. Cancer Chemother Pharmacol 31(Suppl):S51\u2013S54","journal-title":"Cancer Chemother Pharmacol"},{"key":"352_CR20","unstructured":"Kawai S, Tani M, Okamura J et al (1997) Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 24(S6):38-45"},{"key":"352_CR21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF02603139","volume":"16","author":"M Sato","year":"1993","unstructured":"Sato M, Yamada R, Uchida B et al (1993) Effects of hepatic artery embolization with lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16:348\u2013354","journal-title":"Cardiovasc Intervent Radiol"},{"key":"352_CR22","first-page":"185","volume":"53","author":"M Masuda","year":"2002","unstructured":"Masuda M (2002) Evaluation of basic and clinical study on effect of anticancer drugs of lipiodol in chemoembolization on liver tissue. J Wakayama Med Soc 53:185\u2013192","journal-title":"J Wakayama Med Soc"},{"key":"352_CR23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jvir.2009.06.028","volume":"20","author":"S Sahara","year":"2009","unstructured":"Sahara S, Tanihata H, Sato M et al (2009) Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver. J Vasc Interv Radiol 20:1359\u20131364","journal-title":"J Vasc Interv Radiol"},{"key":"352_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004836-200105000-00013","volume":"32","author":"HK Kim","year":"2001","unstructured":"Kim HK, Chung YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423\u2013427","journal-title":"J Clin Gastroenterol"},{"key":"352_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2214\/AJR.08.2301","volume":"195","author":"E Sueyoshi","year":"2010","unstructured":"Sueyoshi E, Hayashida T, Sakamoto I et al (2010) Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Roentgenol 195:245\u2013251","journal-title":"Am J Roentgenol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-012-0352-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0352-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:56:44Z","timestamp":1558720604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-012-0352-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,23]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s00270-012-0352-x","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,23]]}}}